Sonophoresis: What Ultrasound-Assisted Product Delivery Can Mean
Beauty device literacy · Ultrasound
A delivery claim needs an ingredient, a formulation and a measurement.
“Infusion” sounds precise. To understand what it means, ask what crossed the skin barrier—and how anyone measured it.
Short answer
Sonophoresis uses ultrasound to increase skin permeability under defined conditions. It does not prove that every cosmetic ingredient reaches deeper skin with every ultrasonic tool. The acoustic exposure, formulation and skin model must match the claim, and ingredient transport needs direct measurement. A mode called “Infuse,” a smoother feel or a barrier reading cannot establish that result. Research protocols also cannot supply universal home-use settings or permission to combine a device with an arbitrary serum. [1][2]
Start with what “delivery” is supposed to mean
A useful claim names the ingredient, its formulation and the destination being measured. “More absorption” leaves those questions unanswered. It also leaves open whether the result is a laboratory transport measurement or a benefit seen in people.
| Endpoint | What it can establish | What it does not establish by itself |
|---|---|---|
| Ingredient recovered from a skin layer | Retention in the sampled layer, if the assay distinguishes surface residue. | Delivery through the entire skin or a visible benefit. |
| Ingredient collected beyond a skin sample | Permeation through that sample under the experimental conditions. | The same transport in a living face with another tool or serum. |
| Electrical skin resistance | A barrier-related measurement. | The amount or identity of ingredient delivered. |
| Hydration, appearance or user ratings | The reported cosmetic endpoint. | Proof that enhanced ingredient delivery caused the change. |
This distinction is practical: the patch research discussed below measured niacinamide transport and skin resistance separately. A delivery assessment should state which endpoint was tested rather than treating them as interchangeable. [3][4]
The skin barrier is the starting point
The stratum corneum is the outermost epidermal layer. Its closely packed corneocytes and surrounding lipids form a barrier to substances entering the skin. Sonophoresis research investigates how ultrasound changes transport across that barrier. It does not establish that all ingredients in a serum reach the dermis. [2]
Cavitation and streaming describe different physical events
Acoustic cavitation involves gas bubbles responding to sound pressure, including oscillation and collapse. Acoustic streaming is ultrasound-driven fluid movement. Bubble activity can generate local fluid motion, so these mechanisms can interact without being synonyms. Heating can also contribute; the relevant effects depend on the exposure and medium. [1]
Research on sonophoresis discusses bubble-induced mechanical effects near the skin and disruption of its barrier organization. Fluid motion can assist transport near the interface. Their relative contribution is condition-dependent; a frequency label alone does not demonstrate that these effects occurred in a particular skincare tool. [1][2]
Simultaneous delivery and pretreatment are different experiments
Research distinguishes applying ultrasound while the substance is present from applying it before the substance. The table explains that distinction; it is not a suggested skincare sequence. [5]
| Dimension | Simultaneous treatment | Pretreatment |
|---|---|---|
| When the substance is present | During ultrasound exposure, in the coupling medium. | Applied after ultrasound exposure. |
| Transport rationale | Barrier changes and convection-related effects can contribute. | Subsequent transport relies on the induced barrier changes, without concurrent ultrasound-driven convection. |
| Evidence to request | Uptake and formulation compatibility during exposure. | Uptake after exposure and the tested interval before application. |
| Transfer limit | A tested medium does not validate all serums. | A tested interval does not create a universal waiting period. |
Neither approach is automatically better for a consumer device. Keep the study's approach attached to its result; changing the timing changes the question being tested.
Ask for evidence matched to the formulation
A 2023 study reported enhanced niacinamide transport using a specially designed conformable ultrasound patch in a laboratory test with pig skin. It did not test cosmetic improvement in home users. [3]
A related public MIT thesis provides methods: niacinamide in phosphate-buffered saline, skin mounted in a diffusion cell, receptor-fluid sampling and chemical analysis, with passive permeation as a control. This is a defined test solution and apparatus, not an off-the-shelf serum used with a moving spatula. The thesis is a separate primary methods document; it is not the journal article's verified full text. [4]
Use these questions to judge how closely another delivery claim matches its evidence:
- Molecule: Which ingredient was measured? Was it the ingredient itself or a marker?
- Formulation: Was the finished product tested, including its concentration and vehicle?
- Barrier: Was the experiment performed on a synthetic membrane, animal skin, excised human skin or living participants?
- Device: Did the applicator, acoustic exposure and contact arrangement match?
- Outcome: Was ingredient transport measured against the same formulation without ultrasound? Was a human cosmetic benefit tested separately?
A result for one molecule in one vehicle answers that experimental question. It leaves the corresponding claim for another formula or device unverified.
“Infuse” names a mode; it does not measure uptake
For example, the official DERMAPORE+ manual names Extract and Infuse modes and describes ultrasonic and ionic technology. Those are manufacturer descriptions, not independent ingredient-transport results. Where a tool combines acoustic and electrical functions, evidence must also identify which functions were active; the result cannot simply be attributed to ultrasound alone. [6]
The available manual contains an unrelated LUXE+ block and conflicting face-only versus face-and-neck wording. It is not a reliable basis for borrowing a universal treatment sequence, area or frequency. Request the current, unambiguous instructions for the exact model. [6]
Safety belongs to the exact device and combination
Do not turn a laboratory method into a home-use protocol. Confirm permitted formulations, treatment areas, exposure limits and contraindications in the specific device instructions. Increased permeability is not, by itself, evidence of a safe or beneficial skincare result.
The DERMAPORE+ manual, for example, cautions against use on distressed or healing skin and directs users with medical concerns or recent cosmetic procedures to consult a dermatologist. It also directs users to stop and consult a physician if discomfort or worsening skin occurs. These are that device's warnings, not a complete contraindication list for all ultrasound systems. [6]
In the US, cosmetic labeling does not receive advance FDA approval of its claims. Disease or skin structure/function claims can bring drug requirements into consideration; health-related advertising also requires appropriate scientific support. A cosmetic mode name is no evidence of regulatory authorization for drug delivery. These US sources do not establish status in other markets. [7][8]
The useful question is what was measured
Sonophoresis is a real research approach to changing skin transport. For a skincare claim, ask for the tested ingredient, finished formulation, skin model, exact device and measured destination. If those details are missing, “enhanced absorption” remains an unverified claim for that combination.
Sources
- Overview of Therapeutic Ultrasound Applications and Safety Considerations: 2024 Update. Journal of Ultrasound in Medicine, 2025. Mechanisms and skin-permeabilization sections.
- Seah and Teo: Recent advances in ultrasound-based transdermal drug delivery. International Journal of Nanomedicine, 2018. Technical review.
- Yu et al.: A Conformable Ultrasound Patch for Cavitation-Enhanced Transdermal Cosmeceutical Delivery. Advanced Materials, 2023. Abstract verified; journal full text not verified.
- Aastha Shah: A conformable ultrasound patch for cavitation enhanced transdermal cosmeceutical delivery. MIT master's thesis, 2023. Experimental methods and results, pp. 50–58; Appendices B3–B4.
- Martins et al.: Bifunctional Therapeutic Application of Low-Frequency Ultrasound Associated with Zinc Phthalocyanine-Loaded Micelles. International Journal of Nanomedicine, 2020. Introductory distinction between simultaneous treatment and pretreatment; its therapeutic results are not applied to skincare.
- DERMAPORE+ user manual. Manufacturer document; mode labels and model-specific cautions. Mixed-device content and area conflict limit its use here.
- FDA: Cosmetics Labeling Claims. US regulatory context.
- FTC: Health Products Compliance Guidance. US advertising substantiation guidance.
This article is for general educational purposes and does not provide medical advice. Follow the instructions for the specific device and consult a qualified healthcare professional about suitability and safety.